K
Kyverna Therapeutics, Inc. (KYTX)
7.80
0.00 (0.00%)
Get all premium features to the best stock analysis tool
7.80
0.00 (0.00%)
This stock has a consensus price target of $21.50 based on the ratings of 7 analysts. The high is $33.00 and the low is $5.00.
| Target | Lowest Price Target | Consensus Price Target | Highest Price Target |
|---|---|---|---|
| Price | $ 5 | $ 21.5 | $ 33 |
| Change | -35.90% | 175.64% | 323.08% |
| Date | Upside/Downside | Analyst Firm | Price Target | Rating Change | Rating |
|---|---|---|---|---|---|
| 2025-12-16 | 323.08% | Wells Fargo | $31 → $33 | Maintains | Overweight |
| 2025-12-04 | 220.51% | Morgan Stanley | $20 → $25 | Maintains | Overweight |
| 2025-10-30 | 297.44% | Wells Fargo | $27 → $31 | Maintains | Overweight |
| 2025-10-27 | 156.41% | HC Wainwright & Co. | $10 → $20 | Maintains | Buy |
| 2025-10-08 | 246.15% | Wells Fargo | $24 → $27 | Maintains | Overweight |